The global biomaterials market was valued at USD 237.0 billion in 2025 and is expected to reach USD 274.6 billion in 2026. The market is projected to expand to USD 836.5 billion by 2033, registering a CAGR of 17.3% from 2026 to 2033. North America accounted for the largest revenue share at 38.1% in 2025, while Asia Pacific is expected to record the fastest growth over the forecast period.

Increasing demand for medical implants, prosthetics, tissue-engineering products, and advanced surgical devices is supporting market expansion. The rising prevalence of musculoskeletal disorders and chronic skeletal conditions is particularly increasing the need for biomaterial-based implants and other medical solutions.

Biomaterials Market at a Glance

• 2025 market size: USD 237.0 billion
• 2026 estimated market size: USD 274.6 billion
• 2033 projected market size: USD 836.5 billion
• CAGR, 2026–2033: 17.3%
• Leading product segment in 2025: Metallic, with a 40.6% share
• Leading application segment in 2025: Orthopedic, with a 24.9% share
• Largest regional market in 2025: North America, with a 38.1% revenue share
• Fastest-growing region: Asia Pacific
• Leading country in 2025: U.S.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

What Is Driving Biomaterials Market Growth?

Advanced Surgical Procedures Expand Biomaterial Demand

The increasing adoption of minimally invasive and technologically advanced surgical procedures is creating new opportunities for biomaterial manufacturers. Healthcare providers are increasingly using minimally invasive techniques because they can reduce hospital stays, limit postoperative complications, and support faster recovery.

These procedures require materials with a combination of biocompatibility, strength, flexibility, lightweight characteristics, and, in certain applications, controlled bioresorption. Consequently, advanced polymers, composites, ceramics, and bioactive materials are gaining importance across orthopedic, cardiovascular, and general surgical applications.

Robotic-assisted surgery, image-guided interventions, and catheter-based procedures are also increasing the need for precision-engineered biomaterials. Materials used in these applications must provide appropriate mechanical properties, controlled degradation, tissue interaction, and long-term functionality.

This development is supporting innovation in areas such as bioresorbable stents, minimally invasive orthopedic implants, and soft-tissue scaffolds. Growing healthcare accessibility, greater patient awareness, and the increasing burden of chronic diseases are further contributing to demand for advanced surgical technologies.

Download a free sample report or claim your copy of this full market intelligence report

Market Dynamics

Driver: Rising Demand for Medical Implants and Prosthetics

The expanding use of medical implants and prosthetic devices is a major contributor to biomaterials market growth. The prevalence of chronic diseases, musculoskeletal disorders, cardiovascular conditions, dental conditions, and traumatic injuries is increasing demand for implantable medical products worldwide.

Biomaterials are extensively used in orthopedic implants, dental implants, cardiovascular stents, prosthetic devices, and wound-healing products because of their biocompatibility, durability, and ability to interact with biological tissues.

The growing incidence of osteoarthritis, osteoporosis, spinal disorders, and tooth loss is increasing the number of joint replacement and dental restoration procedures. At the same time, population aging and the adoption of minimally invasive surgery are creating additional demand for advanced implantable devices.

Technological developments in metallic, polymeric, ceramic, and bioresorbable biomaterials are improving implant performance and supporting better long-term clinical outcomes.

Sustainability is also emerging as an area of biomaterial innovation. In May 2026, CJ Biomaterials and Yuhan-Kimberly launched in South Korea a biodegradable reusable nonwoven paper towel using amorphous PHA technology. The development represents an application of biomaterial technology aimed at reducing persistent microplastic generation.

Restraint: High Development and Manufacturing Costs

High research, development, testing, regulatory, and manufacturing costs can constrain biomaterial commercialization. Advanced biomaterials often require specialized production processes, extensive performance testing, biocompatibility assessments, and regulatory approvals. These requirements can increase development timelines and raise the investment required to bring innovative materials and products to market.

Biomaterials Industry Structure and Competitive Characteristics

High Innovation Activity

Innovation intensity remains high across the biomaterials industry. Companies and research organizations are advancing bioactive materials, nanotechnology-enabled coatings, bioresorbable polymers, and other specialized material technologies.

The increasing focus on regenerative medicine, personalized implants, and infection-resistant materials is creating opportunities for new product development. Strong research and development spending among established manufacturers, combined with the adoption of advanced surgical technologies, is contributing to continued innovation.

Moderate M&A Activity

Mergers and acquisitions in the biomaterials industry remain moderate and are generally associated with portfolio expansion, technology acquisition, and geographic growth.

Companies are increasingly targeting startups and specialized material developers with technologies relevant to regenerative medicine, minimally invasive procedures, and other high-growth applications. However, large-scale consolidation remains comparatively limited because biomaterial technologies are highly specialized and subject to substantial regulatory requirements.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Biomaterials Market Segmentation Highlights

Product

Metallic biomaterials represented the largest product segment in 2025, accounting for 40.6% of the market. Their established use in orthopedic implants and other medical applications supports their significant market position.

Application

The orthopedic segment held the largest application share in 2025 at 24.9%. Increasing demand for joint replacement, bone repair, and other orthopedic procedures is supporting the use of biomaterials in this segment.

Regional Perspective

North America

North America was the largest regional market in 2025, accounting for 38.1% of global revenue. The region benefits from advanced healthcare infrastructure, established medical device manufacturing capabilities, and demand for sophisticated implantable technologies.

Asia Pacific

Asia Pacific is expected to register the fastest CAGR from 2026 to 2033. Expanding healthcare access, increasing medical procedure volumes, improving healthcare infrastructure, and rising demand for advanced medical technologies are supporting regional growth.

United States

The U.S. held the largest country-level market share in 2025, supported by its developed healthcare system, high adoption of advanced medical technologies, and substantial demand for implantable and surgical products.

Biomaterials Market Forecast, 2025–2033

Leading Biomaterials Companies

Major companies operating in the biomaterials market include:

• Medtronic
• Evonik Industries AG
• Carpenter Technology Corporation
• Berkeley Advanced Biomaterials
• Invibio Ltd.
• Zimmer Biomet Holdings, Inc.
• BASF SE
• Covalon Technologies Ltd.
• Stryker
• Johnson & Johnson

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.